The upcoming 12th Annual Clinical Trials in Oncology conference will cover a wide range of topics on clinical research in ...

In 2025, newly-designed clinical trials for people with cancer are providing new options and hope for patients and their ...

CytoAgents Inc., a clinical-stage biotechnology company developing CTO1681 for the prevention and treatment for Cytokine Release Syndrome (CRS), announced the successful completion of the first dose, ...

The trial will be a collaborative effort between the company, the Norwegian Cancer Society, and Cancer Research UK.

In a Phase 1b/2a trial for lymphoma and cytokine release syndrome, the first group's dose-limiting toxicity observation ...

Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...

The first clinical trial to test whether adults allergic to peanuts can be desensitized has shown great success with two ...

Caribou is enrolling a 20-patient confirmatory cohort using the company's HLA matching strategy in the ANTLER Phase 1 clinical trial in second-line large B cell lymphoma (2L LBCL). In H2 2025, Caribou ...

Letter outlines Phase 3 timeline for PrimeC in ALS, provides update on Canadian regulatory pathway and strategic partnership discussions; Company optimistic about ongoing ...

Controversies in the Treatment of Ischemia-Reperfusion Injury, ” will focus on past and current strategies for reducing the myocardial damage caused by IRI following percutaneous coronary intervention ...

Mumbai: Sun Pharma and Israel-based Moebius Medical Limited have announced the publication of two articles in Osteoarthritis ...

The globalization of clinical research provides ... patients needed in various phases of drug development. Well thought-out regulatory strategies for global trials should be an indispensable ...